Literature DB >> 19375584

Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women.

Alain Veilleux1, Karine Blouin, Caroline Rhéaume, Marleen Daris, André Marette, André Tchernof.   

Abstract

Insulin receptor substrate-1 (IRS-1) and glucose transporter 4 (GLUT4) expression may provide an indirect reflection of the capacity of adipocytes to respond to insulin stimulation. We examined messenger RNA (mRNA) expression of these genes in omental and subcutaneous adipose tissue of women. Paired omental and subcutaneous adipose tissue samples were obtained from 36 women (age, 47 +/- 5 years; body mass index, 28.0 +/- 5.4 kg/m(2)) undergoing gynecologic surgeries. Total adiposity and visceral adiposity were assessed by dual-energy x-ray absorptiometry and computed tomography. The GLUT4 and IRS-1 mRNA expression levels were both significantly higher in subcutaneous compared with omental adipose tissue. A negative correlation was observed between body fat percentage and subcutaneous adipose tissue GLUT4 (r = -0.39, P < .05) and IRS-1 (r = -0.30, P < .08) mRNA abundance. However, in omental fat, only GLUT4 mRNA was inversely associated with body fat percentage (r = -0.53, P < .001). Moreover, the homeostasis model assessment of insulin resistance index was associated with mRNA expression of subcutaneous GLUT4 (r = -0.56, P < .001), subcutaneous IRS-1 (r = -0.51, P < .01), and omental GLUT4 (r = -0.54, P < .001), but not omental IRS-1. Interestingly, plasma adiponectin was only associated with subcutaneous GLUT4 (r = 0.48, P < .01) and IRS-1 (r = 0.48, P < .05) mRNA expression. The GLUT4 protein, unlike mRNA expression, was higher in omental than in subcutaneous adipose tissue. However, abdominal obesity-related differences in protein or mRNA expression were similar. Omental IRS-1 expression was low and unaffected by visceral obesity. In contrast, omental and subcutaneous GLUT4 as well as subcutaneous IRS-1 were reduced in visceral obesity. This divergent pattern of expression may reflect a lower capacity of omental adipose tissue to respond to insulin stimulation at all adiposity levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375584     DOI: 10.1016/j.metabol.2008.12.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans.

Authors:  Derek K Hagman; Ilona Larson; Jessica N Kuzma; Gail Cromer; Karen Makar; Katya B Rubinow; Karen E Foster-Schubert; Brian van Yserloo; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David R Flum; David E Cummings; Mario Kratz
Journal:  Metabolism       Date:  2017-02-02       Impact factor: 8.694

Review 2.  Obesity phenotypes: depot-differences in adipose tissue and their clinical implications.

Authors:  Valeria Guglielmi; Paolo Sbraccia
Journal:  Eat Weight Disord       Date:  2017-12-11       Impact factor: 4.652

3.  IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects.

Authors:  Kelly Cleveland-Donovan; Laura A Maile; William G Tsiaras; Tamara Tchkonia; James L Kirkland; Charlotte M Boney
Journal:  Endocrinology       Date:  2010-06-16       Impact factor: 4.736

Review 4.  Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Mol Aspects Med       Date:  2012-10-13

5.  The SGBS cell strain as a model for the in vitro study of obesity and cancer.

Authors:  Emma H Allott; Elizabeth Oliver; Joanne Lysaght; Steven G Gray; John V Reynolds; Helen M Roche; Graham P Pidgeon
Journal:  Clin Transl Oncol       Date:  2012-08-02       Impact factor: 3.405

Review 6.  Mechanisms of obesity-induced metabolic and vascular dysfunctions.

Authors:  Reem T Atawia; Katharine L Bunch; Haroldo A Toque; Ruth B Caldwell; Robert W Caldwell
Journal:  Front Biosci (Landmark Ed)       Date:  2019-03-01

7.  The MRC1/CD68 ratio is positively associated with adipose tissue lipogenesis and with muscle mitochondrial gene expression in humans.

Authors:  José María Moreno-Navarrete; Francisco Ortega; María Gómez-Serrano; Eva García-Santos; Wifredo Ricart; Francisco Tinahones; Geltrude Mingrone; Belén Peral; José Manuel Fernández-Real
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

8.  Reduced Slc2a4/GLUT4 expression in subcutaneous adipose tissue of monosodium glutamate obese mice is recovered after atorvastatin treatment.

Authors:  Ana Cláudia Poletto; Aline David-Silva; Aline Pedro de Melo Yamamoto; Ubiratan Fabres Machado; Daniela Tomie Furuya
Journal:  Diabetol Metab Syndr       Date:  2015-03-14       Impact factor: 3.320

9.  Decreased RB1 mRNA, protein, and activity reflect obesity-induced altered adipogenic capacity in human adipose tissue.

Authors:  José María Moreno-Navarrete; Petar Petrov; Marta Serrano; Francisco Ortega; Estefanía García-Ruiz; Paula Oliver; Joan Ribot; Wifredo Ricart; Andreu Palou; M Luisa Bonet; José Manuel Fernández-Real
Journal:  Diabetes       Date:  2013-01-11       Impact factor: 9.461

10.  Downregulation of IRS-1 in adipose tissue of offspring of obese mice is programmed cell-autonomously through post-transcriptional mechanisms.

Authors:  Denise S Fernandez-Twinn; Maria Z Alfaradhi; Malgorzata S Martin-Gronert; Daniella E Duque-Guimaraes; Ana Piekarz; David Ferland-McCollough; Martin Bushell; Susan E Ozanne
Journal:  Mol Metab       Date:  2014-01-20       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.